VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$500.86
arrow_downward
-0.77%(-3.87) 1D
Oct 5, 11:07:54 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$504.78
High
$506.01
Low
$496.15
Mkt. cap
126.76B
Avg. vol.
995.37K
Volume
146.74K
P/E ratio
29.10
52-wk high
$560.25
52-wk low
$400.74
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
Open
$504.78
High
$506.01
Low
$496.15
Mkt. cap
126.76B
Avg. vol.
995.37K
Volume
146.74K
P/E ratio
29.10
52-wk high
$560.25
52-wk low
$400.74
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
Zacks
·
2 hours ago
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Yahoo Finance
·
3 hours ago
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
AD HOC NEWS
·
8 hours ago
Vertex Pharma stock pre-market at EUR 450.78: plus 0.37 percent
The Globe and Mail
·
10 hours ago
2 Safe-and-Steady Stocks with Promising Prospects and 1 We Turn Down
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com